Cargando…

Study of CC chemokine receptor 5 in renal allograft rejection

Allospecific recruitment of T cells is primary to the pathogenesis of renal transplant rejection. Chemokines and their receptors inducing a Th1 cytokine response play a central role in this recruitment. Renal allograft biopsies of 28 patients with acute cellular rejection and 10 protocol biopsies (c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, R., Sharma, A., Mitra, D. K., Agarwal, S. K., Dinda, A. K., Saxena, Ankit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692145/
https://www.ncbi.nlm.nih.gov/pubmed/23814418
http://dx.doi.org/10.4103/0971-4065.111848
_version_ 1782274580325335040
author Ghosh, R.
Sharma, A.
Mitra, D. K.
Agarwal, S. K.
Dinda, A. K.
Saxena, Ankit
author_facet Ghosh, R.
Sharma, A.
Mitra, D. K.
Agarwal, S. K.
Dinda, A. K.
Saxena, Ankit
author_sort Ghosh, R.
collection PubMed
description Allospecific recruitment of T cells is primary to the pathogenesis of renal transplant rejection. Chemokines and their receptors inducing a Th1 cytokine response play a central role in this recruitment. Renal allograft biopsies of 28 patients with acute cellular rejection and 10 protocol biopsies (controls) were examined in accordance with Banff grading 2007 schema. Immunohistochemistry for CD3 and CC chemokine receptor 5 (CCR5) in sequential sections was performed and quantitatively assessed in the glomeruli, tubules, and interstitium. Histopathologic and clinical correlations were carried out. CD3- and CCR5-positive cells were observed in significantly higher numbers in rejection cases than in controls (P = 0.010). A larger proportion of CCR5-positive cells were noted in the foci of tubulitis compared to the interstitial infiltrates and glomeruli in all cases, and it correlated with the grade of cellular rejection (P = 0.010). A greater number of CCR5-positive cells were seen in early rejection (<6 months posttransplant) compared to late rejection. No clinical correlation with serum creatinine levels was found. CCR5-positive cells represent the alloaggressive subset of T cells in ACR, and their numbers correlate with rejection severity. CCR5 may be used as a marker of early acute rejection and may be an important target for future antirejection therapies.
format Online
Article
Text
id pubmed-3692145
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36921452013-06-28 Study of CC chemokine receptor 5 in renal allograft rejection Ghosh, R. Sharma, A. Mitra, D. K. Agarwal, S. K. Dinda, A. K. Saxena, Ankit Indian J Nephrol Original Article Allospecific recruitment of T cells is primary to the pathogenesis of renal transplant rejection. Chemokines and their receptors inducing a Th1 cytokine response play a central role in this recruitment. Renal allograft biopsies of 28 patients with acute cellular rejection and 10 protocol biopsies (controls) were examined in accordance with Banff grading 2007 schema. Immunohistochemistry for CD3 and CC chemokine receptor 5 (CCR5) in sequential sections was performed and quantitatively assessed in the glomeruli, tubules, and interstitium. Histopathologic and clinical correlations were carried out. CD3- and CCR5-positive cells were observed in significantly higher numbers in rejection cases than in controls (P = 0.010). A larger proportion of CCR5-positive cells were noted in the foci of tubulitis compared to the interstitial infiltrates and glomeruli in all cases, and it correlated with the grade of cellular rejection (P = 0.010). A greater number of CCR5-positive cells were seen in early rejection (<6 months posttransplant) compared to late rejection. No clinical correlation with serum creatinine levels was found. CCR5-positive cells represent the alloaggressive subset of T cells in ACR, and their numbers correlate with rejection severity. CCR5 may be used as a marker of early acute rejection and may be an important target for future antirejection therapies. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3692145/ /pubmed/23814418 http://dx.doi.org/10.4103/0971-4065.111848 Text en Copyright: © Indian Journal of Nephrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ghosh, R.
Sharma, A.
Mitra, D. K.
Agarwal, S. K.
Dinda, A. K.
Saxena, Ankit
Study of CC chemokine receptor 5 in renal allograft rejection
title Study of CC chemokine receptor 5 in renal allograft rejection
title_full Study of CC chemokine receptor 5 in renal allograft rejection
title_fullStr Study of CC chemokine receptor 5 in renal allograft rejection
title_full_unstemmed Study of CC chemokine receptor 5 in renal allograft rejection
title_short Study of CC chemokine receptor 5 in renal allograft rejection
title_sort study of cc chemokine receptor 5 in renal allograft rejection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692145/
https://www.ncbi.nlm.nih.gov/pubmed/23814418
http://dx.doi.org/10.4103/0971-4065.111848
work_keys_str_mv AT ghoshr studyofccchemokinereceptor5inrenalallograftrejection
AT sharmaa studyofccchemokinereceptor5inrenalallograftrejection
AT mitradk studyofccchemokinereceptor5inrenalallograftrejection
AT agarwalsk studyofccchemokinereceptor5inrenalallograftrejection
AT dindaak studyofccchemokinereceptor5inrenalallograftrejection
AT saxenaankit studyofccchemokinereceptor5inrenalallograftrejection